Condition
Neuromyelitis Optica Spectrum Disorders (NMOSD) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Neuromyelitis Optica Spectrum Disorders (NMOSD) clinical trials that are recruiting, in China. By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Neuromyelitis Optica Spectrum Disorders (NMOSD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Satralizumab in the early treatment of NMOSD attacks: a multicenter real-world study | — | Beijing, Beijing Municipality | Recruiting | Aug 13, 2026 |
| Pregnant Women with Neuroimmune Diseases: A long-term follow-up study | — | Guangzhou, Guangdong | Recruiting | Jun 17, 2026 |
| Modified Zipper Therapy for AQP4‑antibody–positive NMOSD acute attacks | Phase 3 | Tianjin | Recruiting | Feb 19, 2026 |
| Satralizumab in NMOSD: Real-world outcomes from China | — | Shanghai, Shanghai Municipality | Recruiting | Feb 17, 2025 |
| C-CAR168 treatment for autoimmune diseases not responding to standard therapy | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Feb 8, 2024 |
All recruiting trials (5)
-
Satralizumab in the early treatment of NMOSD attacks: a multicenter real-world study
This study tests whether starting Satralizumab during an NMOSD attack is safe and helpful for adults with AQP4-IgG–positive NMOSD.
-
Pregnant Women with Neuroimmune Diseases: A long-term follow-up study
This study follows women with neuroimmune diseases and healthy controls through pregnancy and up to ten years to see how pregnancy affects disease activity and outcomes for both mother and baby.
-
Modified Zipper Therapy for AQP4‑antibody–positive NMOSD acute attacks
This trial will test whether adding immediate eculizumab to high‑dose steroids and plasma exchange helps adults with AQP4‑antibody–positive NMOSD recover better from acute attacks.
-
Satralizumab in NMOSD: Real-world outcomes from China
This study looks at how satralizumab works for Chinese patients with NMOSD in everyday clinical care by following people over time.
-
C-CAR168 treatment for autoimmune diseases not responding to standard therapy
This study is testing a new treatment called C-CAR168 to see if it can help adults with autoimmune diseases that haven't improved with standard therapies.
Related topics
Quick answers
How many Neuromyelitis Optica Spectrum Disorders (NMOSD) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.